Penny Stock Alerts From AimHighProfits: OncoSec Medical Inc. (ONCS)

FACT: The RIGHT Penny Stocks offer the HIGHEST percentage gains of any stocks in the market.
 
July 9, 2012 - PRLog -- AimHighProfits tracks penny stocks daily and is pleased to offer its penny stock alerts. Investors can receive FREE Penny Stock Alerts, company news and profiles by visiting AimHighProfits. We know Penny Stocks and If you CAN'T make money with AimHighProfits Penny Stock Newsletter, then you shouldn't be Trading Penny Stocks.

http://www.aimhighprofits.com/we-know-penny-stocks

Today's penny stock alert: OncoSec Medical, Inc.

OncoSec Medical, Inc. is a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors. There are 87.86 million shares outstanding and ONCS stock has gained 38.89% over the last 5 days.

For more information about ONCS stock, visit: http://www.aimhighprofits.com/penny-stock-pick-of-the-week-oncosec-medical-oncs-14717

OncoSec Medical received Investigational Review Board (IRB) approval at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center for a Phase II clinical trial evaluating OncoSec's OMS ElectroImmunotherapy for the treatment of cutaneous T-cell lymphoma. UCSF investigators are actively recruiting for this clinical trial.

A total of up to 27 patients with cutaneous T-cell lymphoma will be enrolled in this Phase II, single-arm, open-label multi-center study. The trial's primary endpoint is to assess local and distant response rate following treatment of cutaneous T-cell lymphoma lesions (mycosis fungoides or Sezary patients) with a DNA-based cytokine coded for the immune stimulating agent interleukin-12 (DNA IL-12) and electroporation. One treatment cycle will consist of three treatments applied to up to four lesions on days one, five and eight with a maximum dose of 3.0 mg DNA IL-12 per treatment cycle.  

Patients with stable disease or better at three months will be eligible to receive a second treatment cycle. Additional treatment cycles at six, nine and 12 months can be applied if there is no evidence of disease progression or intolerability of the treatment, with a maximum of four cycles. Treatment response at untreated sites will be evaluated according to the standard modified SWAT definition. At 12 months, patients will be moved to the follow-up phase of the study and will be followed for up to five years for safety. The first patient has been enrolled and successfully completed their first treatment cycle.

ABOUT AimHighProfits

AimHighProfits (http://AimHighProfits.com) is a penny stock watch website that provides free daily alerts on penny stocks. AimHighProfits' penny stock alerts include news releases or daily e-mails on Small-Cap and Micro-Cap stocks in all sectors of the market. These include stocks with high or low volume, penny stocks, stocks with technical indicators and much more. AimHighProfits tracks stocks that may be moving upwards or downwards. AimHighProfits also features companies on its website with company profiles, research reports, analysis, and newsletters.

AimHighProfits is an independent electronic publication that provides information on selected publicly traded companies. AimHighProfits is not a registered investment advisor or broker-dealer. AimHighProfits including affiliates, officers, directors, contractors and employees may buy, sell or hold shares in any company mentioned herein and may profit in the event those shares increase or decrease in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

Disclaimers-

Release of Liability: Through use of this website viewing or using you agree to hold AimHighProfits.com, its operators, owners, and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities.

The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. AimHighProfits encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and AimHighProfits makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. AimHighProfits has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. AimHighProfits also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in any stock (large-cap, small-cap, or micro-cap security) is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. AimHighProfits makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through AimHighProfits.com. AimHighProfits owners may or may not hold positions in any of the companies that are profiled.

The following report is neither an offer to buy or sell securities. This disclaimer is to be read and fully understood before using our site, or joining our email list.
End
Email:***@aimhighprofits.com Email Verified
Phone:561-880-4615
Zip:33410
Tags:ONCS, ONCS stock, OncoSec Medical, Penny Stock Alerts
Industry:Investment
Location:Palm Beach Gardens - Florida - United States
Subject:Projects
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share